Skip to main content

Table 2 Incidence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (DM) during the five years follow-up after hospitalisation

From: A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes

  Hyperglycaemia group Normoglycaemia group Relative risk
Finished follow-up    
   - sepsisa 70 139  
   - ACSb 75 153  
   - other diagnoses 48 106  
all patients 193 398  
New IFG or IGT    
   - sepsisa 18 18 2.1 (95% CI 1.3 to 4.1)
   - ACSb 19 17 2.6 (95% CI 1.4 to 4.6)
   - other diagnoses 10 14 1.9 (95% CI 0.9 to 3.9)
all patients 47 (24.4%) 49 (12.3%) 2.3 (95% CI 1.6 to 3.4)
New Type 2 DM    
   - sepsisa 13 6 5.0 (95% CI 2.0 to 12.5)
   - ACSb 10 4 6.0 (95% CI 1.9 to 18.5)
   - other diagnoses 10 4 6.0 (95% CI 2.0 to 18.1)
all patients 33 (17.1%) 14 (3.5%) 5.6 (95% CI 3.1 to 10.2)
Remained normoglycaemic    
   - sepsisa 39 115  
   - ACSb 46 132  
   - other diagnoses 28 88  
all patients 113 (58.5%) 335 (84.2%)  
  1. a includes severe sepsis and septic shock
  2. b ACS, acute coronary syndrome (unstable angina and myocardial infarction